A local biopharmaceutical company challenged December 28 decision by the Korean Intellectual Property Tribunal to disapprove of its anti-obesity related patent right.
CTCBIO said it wouldn't accept the decision.
"Discussions are ongoing about how to respond. It could be a direct appeal to a patent court," a CTCBIO spokesman said.
“We will do our best to demonstrate our patent’s novelty...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.